TMC Life Sciences Berhad Statistics

Total Valuation

KLSE:TMCLIFE has a market cap or net worth of MYR 801.27 million. The enterprise value is 864.61 million.

Market Cap	801.27M
Enterprise Value	864.61M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

KLSE:TMCLIFE has 1.74 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.74B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.87%
Owned by Institutions (%)	1.37%
Float	308.63M

Valuation Ratios

The trailing PE ratio is 62.16.

PE Ratio	62.16
Forward PE	n/a
PS Ratio	2.48
PB Ratio	0.94
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	21.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.26, with an EV/FCF ratio of -533.71.

EV / Earnings	66.65
EV / Sales	2.68
EV / EBITDA	18.26
EV / EBIT	40.76
EV / FCF	-533.71

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.23.

Current Ratio	1.99
Quick Ratio	1.87
Debt / Equity	0.23
Debt / EBITDA	4.17
Debt / FCF	-121.91
Interest Coverage	2.13

Financial Efficiency

Return on equity (ROE) is 1.50% and return on invested capital (ROIC) is 1.24%.

Return on Equity (ROE)	1.50%
Return on Assets (ROA)	1.13%
Return on Invested Capital (ROIC)	1.24%
Return on Capital Employed (ROCE)	2.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	16.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.78% in the last 52 weeks. The beta is 0.52, so KLSE:TMCLIFE's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-34.78%
50-Day Moving Average	0.42
200-Day Moving Average	0.51
Relative Strength Index (RSI)	61.39
Average Volume (20 Days)	154,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:TMCLIFE had revenue of MYR 322.59 million and earned 12.97 million in profits. Earnings per share was 0.01.

Revenue	322.59M
Gross Profit	108.46M
Operating Income	21.21M
Pretax Income	16.76M
Net Income	12.97M
EBITDA	45.12M
EBIT	21.21M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 134.15 million in cash and 197.49 million in debt, giving a net cash position of -63.35 million or -0.04 per share.

Cash & Cash Equivalents	134.15M
Total Debt	197.49M
Net Cash	-63.35M
Net Cash Per Share	-0.04
Equity (Book Value)	851.42M
Book Value Per Share	0.49
Working Capital	105.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 36.59 million and capital expenditures -38.21 million, giving a free cash flow of -1.62 million.

Operating Cash Flow	36.59M
Capital Expenditures	-38.21M
Free Cash Flow	-1.62M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 33.62%, with operating and profit margins of 6.57% and 4.02%.

Gross Margin	33.62%
Operating Margin	6.57%
Pretax Margin	5.20%
Profit Margin	4.02%
EBITDA Margin	13.99%
EBIT Margin	6.57%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 4.67%.

Dividend Per Share	0.02
Dividend Yield	4.67%
Dividend Growth (YoY)	163.93%
Years of Dividend Growth	3
Payout Ratio	297.66%
Buyback Yield	n/a
Shareholder Yield	4.67%
Earnings Yield	1.62%
FCF Yield	-0.20%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KLSE:TMCLIFE has an Altman Z-Score of 2.97. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.97
Piotroski F-Score	n/a